05.07.15
Salt Lake City, Utah-based Perseon Corporation, maker of cancer treatment systems, has named Rick Gaykowski as vice president of regulatory, quality and clinical affairs.
“Rick is a 25-year veteran of regulatory affairs and brings a long track record of success to our team,” said Clint Carnell, CEO of Perseon. “His high caliber of expertise and extensive relationships will be invaluable to Perseon as we continue to enhance our evidence-based approach and expand our speed of innovation within the high-growth energy ablation market.”
Over his 25-year career, Gaykowski has held various management and leadership positions within the medical device and healthcare industries. Most recently he was global vice president, regulatory affairs and quality systems for Lumenis, a manufacturer of medical laser equipment. Before joining Lumenis in 2010, Gaykowski served as vice president, regulatory affairs for Bard Access Systems Inc., and earlier, he held various leadership positions in regulatory affairs and quality assurance at Boston Scientific, InnerDyne Inc., CardioPulmonics Inc., and Symbion Inc. He holds a bachelor’s degree in behavioral sciences and health from the University of Utah.
“Rick is a 25-year veteran of regulatory affairs and brings a long track record of success to our team,” said Clint Carnell, CEO of Perseon. “His high caliber of expertise and extensive relationships will be invaluable to Perseon as we continue to enhance our evidence-based approach and expand our speed of innovation within the high-growth energy ablation market.”
Over his 25-year career, Gaykowski has held various management and leadership positions within the medical device and healthcare industries. Most recently he was global vice president, regulatory affairs and quality systems for Lumenis, a manufacturer of medical laser equipment. Before joining Lumenis in 2010, Gaykowski served as vice president, regulatory affairs for Bard Access Systems Inc., and earlier, he held various leadership positions in regulatory affairs and quality assurance at Boston Scientific, InnerDyne Inc., CardioPulmonics Inc., and Symbion Inc. He holds a bachelor’s degree in behavioral sciences and health from the University of Utah.